Germany's healthcare industry is Europe’s largest, valued at around €538 billion in 2024. The sector accounts for roughly 12 percent of the country’s GDP and serves more than 83 million people. With strong public and private spending, it offers a stable, high-volume market for products and services across pharmaceuticals, medical technology, biotechnology and digital health.

Yes – Germany combines Europe’s largest healthcare market with strong growth drivers such as an ageing population, rising healthcare spending and top research infrastructure. Investors benefit from a transparent regulatory framework, robust IP protection and access to skilled talent across Germany's pharmaceutical industry, medical technology, biotechnology and digital health.

Inmedical technology, Germany offers strong growth in minimally invasive surgery, advanced diagnostics and imaging technologies, supported by export leadership and high R&D intensity. The Digital Health sector is advancing rapidly in telemedicine platforms, AI-driven diagnostics and DiGA-approved digital therapeutics, backed by progressive legislation. In Germany's pharmaceutical industry, biologics, oncology treatments and mRNA-based vaccines benefit from leading biotech clusters, strong manufacturing capacity and extensive clinical trial networks.

Germany is advancing fast in AI-powered diagnostics, digital therapeutics approved under the DiGA pathway and integrated health data platforms. Germany's biotech sector is seeing strong momentum in mRNA technology, cell and gene therapies as well as biologics, supported by leading research clusters and targeted public funding. In pharmaceuticals, these innovations align with advanced manufacturing capacity and robust clinical trial networks.

Quality and patient safety are top priorities in Germany's healthcare industry, which is why it is highly regulated with clear approval processes and strict compliance standards. Understanding these rules early and working with local partners is essential. Our experts from GTAI can guide you through requirements and help ensure a smooth, successful market entry.

Germany supports healthcare innovation through generous R&D grants, investment allowances and funding programs such as the Central Innovation Program for SMEs (ZIM). Sector-specific initiatives back Germany’s biotechnology, digital health and pharmaceutical projects. Our GTAI experts can connect you with the right funding programs to support your venture into Germany's healthcare industry.